Asprosin immunoreactivity was found to be significantly higher in colon carcinoma tissues than in healthy colon tissues (0.4 ± 0.07, 1.08 ± 0.15, respectively) (p < 0.001) (Table 1). Here, FBN1 is linked to colon carcinoma.